Cargando…
Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
Breast cancer is one of the most common malignant tumors in women worldwide. Early diagnosis, treatment, and prognosis of breast cancer are global challenges. Identification of valid predictive diagnosis and prognosis biomarkers and drug targets are crucial for breast cancer prevention. This study c...
Autores principales: | Fang, Leiming, Liu, Qi, Cui, Hongtu, Zheng, Yunji, Wu, Chengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027215/ https://www.ncbi.nlm.nih.gov/pubmed/35456460 http://dx.doi.org/10.3390/genes13040654 |
Ejemplares similares
-
Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment
por: Cui, Hongtu, et al.
Publicado: (2022) -
CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a
bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022) -
CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis
por: Li, Qianru, et al.
Publicado: (2019) -
The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication
por: Peng, Wei, et al.
Publicado: (2022) -
Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
por: Yi, You-Cai, et al.
Publicado: (2021)